Every treatment, comparison, and safety guide on RunawayHair - each graded A–D on the evidence and cited. New pages are added as the research and the pipeline move.
Start here
- The Treatment Evidence MapThe interactive map of every option, graded A to D.
Experimental & pipeline
- B Clascoterone (Breezula) for hair loss: what the evidence showsTopical androgen-receptor blocker. Phase 3 done, not yet approved.
- C PP405: waking dormant follicles, explainedWakes dormant follicle stem cells. Phase 2a - a genuinely new mechanism.
- The experimental hair-loss pipeline, trackedEvery pipeline drug in one place, by trial stage. Updated as data lands.
- B VDPHL01: extended-release oral minoxidil, explainedExtended-release oral minoxidil on an FDA approval track. Phase 3.
Head-to-head comparisons
- A Dutasteride vs finasteride: what the evidence actually saysWhich lowers DHT more, and whether that means better.
- A Oral vs topical minoxidil: how to choosePill or scalp: effectiveness, convenience, and side effects.
How the treatments work
- A 5-alpha reductase inhibitors for hair loss, explainedHow finasteride and dutasteride lower DHT, and the trade-off.
Natural & adjunct options
- B Ketoconazole shampoo for hair loss: what the evidence showsA legitimate adjunct, not a standalone treatment.
- C Rosemary oil for hair growth: what the evidence actually saysThe one botanical with a real randomized trial behind it.
Safety & side effects
- B Oral minoxidil side effects: the honest rundownThe real numbers from a 1,404-patient safety study.
- Post-finasteride syndrome: an honest look at the evidenceWhat is established, what is contested. No hype, no dismissal.